Association of tyrosine protein kinase Zap-70 with the protooncogene product p120c-cbl in T lymphocytes by unknown
Brief Definitive Report 
Association  of Tyrosine Protein Kinase  Zap-70 with the 
Protooncogene  Product p120  c-cbl in T  Lymphocytes 
By Marielle Fournel,* Dominique Davidson,* RobertWeil,* 
and Andr~ Veillette**~l~l** 
From the *McGill Cancer Centre and Departments of*Medicine, ~  Biochemistry, and IlOncology, 
McGill University, Montr&l, Canada H3G 1Y6; and the Departments of￿82  and 
** Oncology, Montreal General Hospital, Montr&l, Canada H3G IA4 
Summary 
Accumulating data show that the tyrosine protein kinase Zap-70 plays an essential role in T  cell 
receptor-mediated signal transduction. However, the mode of action, as well as the physiolog- 
ically relevant substrates  of Zap-70, have not been determined. We have attempted to identify 
a  120-kD tyrosine-phosphorylated protein (p120)  that associates  with Zap-70 in activated T 
lymphocytes. The results  of our analyses showed that p120 is largely encoded by the c-cbl pro- 
tooncogene. Furthermore, the association of Zap-70 with c-Cbl was shown to be induced by 
T  cell receptor stimulation, implying that it required posttranslational modification of one or 
both of these products. FynT, but not Lck, also associated with c-Cbl in activated T  cells. Fi- 
nally, using a heterologous system, it was demonstrated that the ability of Zap-70 to cause ty- 
rosine phosphorylation of p120  c-cbl was dependent on Lck- or FynT-mediated signals. As c-Cbl 
can associate  with several other signaling molecules, it may couple Zap-70 to downstream es 
lectors during T  cell activation. 
S 
timulation of T  lymphocytes by antigen or anti-TCR 
antibodies causes  a rapid tyrosine protein phosphoryla- 
tion signal  (for review, see references 1-4). Accumulating 
evidence shows  that  this  signal  is  initiated  by p56  kk  and 
p59  fynT, two  members  of the  Src  family abundantly  ex- 
pressed in T  lymphocytes (for review, see references 1-5). 
This  function  presumably  reflects the  ability  of Lck  and 
FynT to phosphorylate specific tyrosine residues in the cy- 
toplasmic domains of the  CD3  and ~ chains of the TC1K 
complex. Subsequent to this event, Zap-70, a member of 
the Syk/Zap-70 family of cytoplasmic tyrosine protein ki- 
nases,  associates  with tyrosine-phosphorylated CD3  and 
through its tandem amino-terminal Src homology 2 (SH2) 
domains (6-9). This association is paralleled by an increase 
in  the  tyrosine  phosphorylation  and  catalytic  activity  of 
Zap-70.  The importance of Zap-70  in  TC1K  signaling is 
highlighted by the finding that a subset of humans with se- 
vere  combined  immunodeficiency has  mutations  in  the 
zap-70 gene (10-12). 
The identity of the targets of Zap-70 in T lymphocytes is 
not known.  However, we  previously found that  Zap-70 
associates with a 120-kD tyrosine-phosphorylated polypep- 
tide  (p120)  in  activated T  ceils  (13,  14).  This  association 
was shown to involve a pool of Zap-70 molecules not asso- 
ciated  with  TC1K.  Moreover,  it  seemingly  required  the 
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presence of phosphorylated tyrosine residues, as it could be 
efficiently competed by addition ofphosphotyrosine to cell 
lysates.  Whereas the identity of p120 could not be estab- 
lished in  this  earlier study,  evidence was  provided that it 
was distinct from phosphatidyl inositol 3' kinase, GTPase- 
activating protein of p21 ~a~ and focal adhesion kinase (Fak). 
Furthermore, while the  120-kD  product of the c-cbl pro- 
tooncogene (p120  ~-~bl) is prominently tyrosine phosphory- 
lated  in  activated T  cells,  we  failed to  detect Zap-70  in 
anti-Cbl immunoprecipitates, suggesting that the Zap-70- 
associated p120 was also distinct from c-Cbl. 
The cbl gene was initially identified in a rearranged form, 
as the oncogene of the Cas-Br-M murine leukemia virus, 
which causes pre-B cell lymphomas and myeloid leukemias 
in mice  (15).  Cloning of the c-cbl protooncogene showed 
that it encodes a 120-kD protein bearing a proline-rich do- 
main and a possible carboxy-terminal leucine zipper (16). 
While c-cbl is expressed in several cell types, it preferentially 
accumulates in thymus and testis, as well as in hemopoietic 
cells  (17).  A  role for c-Cbl in  hemopoietic cell signaling 
was  suggested  by  the  recent  finding  that  it  undergoes 
prompt tyrosine phosphorylation after stimulation of the T 
cell receptor for antigen (18), the Fc receptor for IgG (19), 
and  the  receptors  for  GM-CSF  and  erythropoietin (20). 
Furthermore, it has been documented that c-Cbl can bind 
a multitude of SH2 and/or SH3  domain-containing pro- 
teins, through its tyrosine-phosphorylated region and pro- 
line-rich  domain,  respectively  (18).  These  Cbl-binding 
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phosphatidyl  inositol  3'  kinase,  and  phospholipase  C-y, 
which  are  likely involved in  regulating and/or  mediating 
Cbl-related functions. 
Materials  and Methods 
Cells.  BI-141  is a class II MHC-restricted, beef insulin-spe- 
cific mouse T cell hybridoma, which lacks expression of CD4 and 
CD8  (2l, 22).  It was propagated in R.PMI 1640 medium supple- 
mented with  10% fetal bovine serum and, if indicated, the ami- 
noglycoside G418  (0.6 rag/nil). BI-141 derivatives expressing an 
activated version  of p56  l~k  (tyrosine 505  to  phenylalanine  505 
[F505] Lck) have been described elsewhere (21). Cos-i cells were 
propagated in ot MEM with 10% fetal bovine serum. 
Antibodies.  Antibodies  against  p120  ~-cbl were  produced  by 
immunizing New Zealand White rabbits with a TrpE fusion pro- 
tein encompassing amino acids 541-886 of the mouse c-Cbl se- 
quence.  Rabbit antisera  directed against the  unique  domain  of 
p56 lck (23) or p59#  n (22),  or the "linker" region of Zap-70 (13), 
were described elsewhere. Affinity-purified  rabbit antiphosphoty- 
rosine antibodies were previously reported (21, 22). 
Antibody-mediated  T  CellActivation.  BI-141  cells  (1  ￿  107) 
were stimulated for 2 min with saturating amounts of anti-TCR 
V~8 mouse mAb F23.1  (24) and sheep anti-mouse (SAM) IgG, as 
outlined elsewhere (21, 22). After stimulation, cells were lysed in 
2￿  TNE buffer (100 mM Tris, pH 8.0,  2% NP-40, and 40 mM 
EDTA), supplemented with 20 p~g/ml each of the protease inhib- 
itors leupeptin, aprotinin,  N-tosyl-L-phenylalanine chloromethyl 
ketone,  N-p-tosyl-L-lysine chloromethyl ketone,  and  PMSF,  as 
well as the phosphatase inhibitors sodium fluoride (100 raM) and 
sodium orthovanadate (2 mM). 
Immunoprecipitations and lmmunoblots.  Unless  indicated,  post- 
nuclear  supematants  were  precleared with  Staphylococcus aureus 
protein A. Then,  lysates were immunoprecipitated with the ap- 
propriate antisera, according to  a  previously described protocol 
(25).  For  depletion  experiments,  lysates  were  immunoprecipi- 
tated three times with either normal rabbit serum (NRS) or anti- 
Cbl  antibodies,  before  a  final  inmmnoprecipitation with  anti- 
Zap-70 or anti-Cbl antibodies. Immunoblots were performed as 
detailed elsewhere (23, 25). 
Coexpression in Cos-l Cells.  cDNAs encoding mouse Zap-70 
(8), p56  kk (26),  or p59  frnx (27)  were reported elsewhere. A c-cbl 
cDNA was generated by PCI< from mouse thymus RNA, based 
on the published sequence (our unpublished data),  cDNAs were 
individually inserted  in  the  multiple  cloning  site  of pXM139, 
which  bears  the  SV40  origin  of replication.  Cos-1  cells  were 
transfected  by  the  DEAE-dextran  method,  using  a  fixed  total 
amount  of DNA (12  btg) (28).  After 12  h,  cells were incubated 
with chloroquine (60 btg/ml) for 5 h. After an additional growth 
period of 48 h, cells were harvested by scraping, and lysed in 1 ￿ 
TNE  buffer  (50  mM  Tris,  pH  8.0,  1%  NP-40,  and  2  n-tM 
EDTA), supplemented with the protease and phosphatase inhibi- 
tors described above. Then,  lysates  were  subjected to  immuno- 
blotting or imnmnoprecipitation, as outlined earlier. 
Results 
To  evaluate better the possibility that Zap-70  associates 
with  the  c-Cbl  protein,  we  generated  a  highly  sensitive 
rabbit antiserum against the  Cbl protein (see Materials and 
Methods).  This  reagent was  used  to  study further  the po- 
tential association of Zap-70 with c-Cbl in BI-141  cells ex- 
pressing  an  activated  version  of  p56  lck  (F505  Lck;  21), 
which  exhibit  a  greatly enhanced  TCR-induced  tyrosine 
protein phosphorylation signal. After activation with  anti- 
TCR  antibodies,  cells were  lysed in  nonionic  detergent- 
containing  buffer.  Postnuclear  lysates  were  then  immu- 
noprecipitated  with  various  antibodies,  and  subjected  to 
immunoblotting  with  antiphosphotyrosine  (Fig.  1  A)  or 
anti-Cbl (Fig.  1  B)  antibodies. As previously reported (13, 
14),  activated  BI-141  cells  contained  easily  detectable 
amounts of tyrosine-phosphorylated Zap-70 (Fig. 1 A, lane 
2).  Additionally, Zap-70  immunoprecipitates  exhibited  a 
120-kD tyrosine-phosphorylated protein (p120).  Also con- 
sistent with  our  earlier report  (13),  anti-Cbl immunopre- 
cipitates  (lane  3)  from  activated BI-141  cells  contained  a 
120-kD  tyrosine-phosphorylated product, representing the 
c-Cbl protein.  However,  no  tyrosine-phosphorylated p70 
was detected in these immunoprecipitates. When identical 
immunoprecipitates  were  immunoblotted  with  anti-Cbl 
antibodies  (Fig.  1  /3),  significant quantities  of c-Cbl were 
noted in  anti-Zap-70  immunoprecipitates (lane 2).  It was 
estimated that 5-10%  of c-Cbl was present in anti-Zap-70 
immunoprecipitates.  Coimmunoprecipitation  of  Zap-70 
and c-Cbl was also observed in normal mouse  thymocytes 
(our unpublished data). 
Figure 1.  Association  of Zap-70 with c-Cbl in ac- 
tivated BI-141 T-cells. BI-141 cells  expressing acti- 
vated p56  kk  molecules were  stimulated for  2  rain 
with anti-TCR mAb F23.1 and SAM lgG. After ex- 
traction in nonionic detergent-containing buffer, ly- 
sates were subjected to immunoprecipitation with the 
indicated antibodies, and immunoblotting  with  an- 
tiphosphotyrosine  (A)  or  anti-Cbl  (/3) antibodies. 
The positions of p120, Zap-70, heavy chain of IgG, 
and c-Cbl are indicated on the left, while those of 
prestained molecular mass markers are shown on the 
right. Exposures: 15 h. 
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was c-Cbl, depletion experiments were conducted (Fig. 2). 
Lysates from  activated B1-141  cells were  subjected to  re- 
peated immunoprecipitations with either NRS  (lanes  I-3) 
or anti-Cbl antibodies  (lanes  4-6).  After three  cycles,  the 
remaining cellular proteins were immunoprecipitated with 
either anti-Cbl (lanes 7 and  8)  or anti-Zap-70 (lanes 9  and 
10)  serum,  and probed by immunoblotting with antiphos- 
photyrosine antibodies. Using this approach,  >90%  of ty- 
rosine-phosphorylated c-Cbl molecules was removed with 
one  Cbl  immunoprecipitation  (lane  4),  and  nearly  100% 
was eliminated after two precipitations (lane 8).  After three 
c-Cbl immunoprecipitations, we found that <10% of Zap- 
70-associated p120  remained  in  cell lysates  (lane  10;  data 
not shown). In combination, these results indicated that the 
Zap-70--associated p120 mostly represented p120  c-cbl. How- 
ever,  as longer autoradiographic exposures clearly showed 
that  N10%  of p120  remained  after  immunodepletion  of 
c-Cbl (data not shown),  it is possible that one or more ad- 
ditional p120s were also associated with Zap-70. While the 
identity of these products  is not  known,  they may  corre- 
spond  to  the  recently  described  focal  adhesion  kinase- 
related FakB (29). 
We also investigated whether the  association of Zap-70 
with c-Cbl was constitutive, or was induced by T  cell acti- 
vation.  Cells were  either  left  unstimulated,  or  stimulated 
with  anti-TCP,,  antibodies.  Anti-Cbl  immunoblotting  of 
Zap-70 immunoprecipitates revealed that the association of 
Zap-70 with c-Cbl was  undetectable in unstimulated cells 
(Fig. 3, lane  1),  and that it was induced by TCR  stimula- 
tion (lane 2). Anti-Cbl immunoblotting of parallel Cbl im- 
munoprecipitates  demonstrated  that  the  abundance  of 
p120  c-cbi was not augmented during T  cell aotivation (lanes 
3 and 4). 
To  examine  the  specificity of the  interaction  between 
Zap-70  and  c-Cbl, we  assessed the  ability of Cbl  to  bind 
p561ok and  p59  eynT, the  two  other  tyrosine protein  kinases 
implicated in TCR  signaling (for review, see references 1-4). 
After  detergent  extraction,  lysates  from  activated  BI-141 
cells  were  immunoprecipitated  with  antibodies  directed 
against the unique  domain of Lck or FynT, and were im- 
munoblotted  with  anti-Cbl  serum  (Fig.  4  A).  We  found 
that anti-Fyn immunoprecipitates (lane 5) contained appre- 
ciable quantities of p120  c-cbl. However, these amounts were 
consistently lower than those observed in anti-Zap-70 im- 
munoprecipitates (lane 2;  data not shown).  In contrast, no 
c-Cbl was detected in anti-p561ok immunoprecipitates (lane 
4) or in immunoprecipitates generated with preimmune se- 
rum  (lane  1).  Similar results  were  obtained  with  BI-141 
cells  expressing  a  constitutively activated  form  of p59  cxnT 
(data not shown).  Given these results, we wanted to estab- 
lish whether the binding of c-Cbl to  FynT was also regu- 
lated by TCP,. stimulation. Evaluation of both unstimulated 
and TCR-stimulated BI-141  cells revealed that the interac- 
Figure  2.  Effects of immunodepletion  of c-Cbl on  the  recovery of 
Zap-70-associated p120. Lysates from activated BI-141 cells  were sub- 
jected to repeated immunoprecipitations with NIKS or anti-Cbl antibod- 
ies, before a final immunoprecipitation with anti-Cbl (lanes 7 and 8) or 
anti-Zap-70 (lanes 9 and  10) antibodies. Tyrosine-phosphorylated pro- 
teins were detected by immunoblotting with  antiphosphotyrosine anti- 
bodies. The presence ofa tyrosine-phosphorylated 70-kD protein in im- 
munoprecipitates obtained with normal rabbit serum (lane 1) or anti-Cbl 
antibodies (lane 4) was due to recovery ofTCP,-associated Zap-70 mole- 
cules with the combination of mAb F23.1 and SAM IgG used for TCP,. 
aggregation. Because a preclearing step was not used in this expemnent, 
the  anti-TCR immune  complexes were  nonspecifically precipitated by 
the  Staphylococcus aureus protein A. The positions of p120, Zap-70, and 
heavy chain of IgG are shown on the left, while those ofprestained mo- 
lecular weight markers are indicated on the right. Exposures: 24 h. 
Figure 3.  Association of Zap-70 with c-Cbl is induced by T cell acti- 
vation. BI-141 cells were either left unstimulated (lanes 1 and 3), or stim- 
ulated with mAb F23.1 and SAM IgG (lanes 2 and 4). The abundance of 
Zap-70-associated p120  c cbl was determined by immunoblotting of anti- 
Zap-70  inununoprecipitates with  anti-Cbl  antibodies (lanes 1 and  2), 
while the cellular levels of c-Cbl were determined by anti-Cbl immuno- 
blotting ofanti-Cbl immunoprecipitates (lanes 3 and 4). The migration of 
c-Cbl is indicated on the left. Exposures: lanes I and 2; 18 h; lanes 3 and 
4; 5b. 
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BI-141 cells. (A) BI-141 cells containing F505 Lck were stimulated with 
anti-TCR mAb F23.1 and SAM IgG for 2 rain. Lysates  were then immu- 
noprecipitated with various antibodies, followed  by inununoblotting with 
anti-Cbl antibodies. The migrations of c-Cbl and heavy chain of IgG are 
shown on the left. Exposure: 84 h. (B) Same as in A, except that cells 
were either left unstimulated or stimulated with anti-TCR mAb F23.1 
and SAM IgG. Lysates  were immunoprecipitated with anti-Fyn antibod- 
ies, and immunoblotted with anti-Cbl serum. The position of c-Cbl is in- 
dicated on the left. Exposure:  24 h. 
tion ofc-Cbl with p59  fynT was absent before TCR. stimulation 
(Fig. 4 B, lane  1). Therefore, as is the case for the Zap-Cbl 
association, the detection of FynT-Cbl complexes required 
activation ofBI-141 T  cells. 
To  understand  better  the  respective  roles  of Zap-70, 
p5ff  ok,  and  p59  eynT  in  the  tyrosine  phosphorylation  of 
c-Cbl, we attempted to reconstitute their functional inter- 
actions  in  nonlymphoid  Cos-1  cells,  cDNAs  encoding 
these  kinases  were  transfected  either  individually  or  in 
combination, in the presence of a mouse c-cbl cDNA. After 
3  d,  cells  were  lysed  in  detergent-containing  buffer,  and 
postnuclear lysates were directly probed by immunoblotting 
(Fig.  5).  Using a  panel  of antisera  directed  against  c-Cbl, 
Zap-70,  Fyn,  and  Lck,  it was  confirmed that  all  cells  ex- 
pressed  the  appropriate  cDNAs  (Fig.  5  A).  Through  an- 
tiphosphotyrosine immunoblotting of total cell lysates (Fig. 
5 B), we also determined that c-Cbl was not tyrosine phos- 
phorylated in Cos-1 cells in the absence of coexpression of 
a  tyrosine  protein  kinase  (lane  2).  Introduction  of FynT 
(lane 3) or Lck (lane 4) provoked an appreciable augmenta- 
tion of the phosphotyrosine content of c-Cbl.  In contrast, 
expression  of Zap-70  alone  (lane  5)  had no impact.  Inter- 
estingly though, Zap-70 increased by approximately three- 
fold the effects of FynT (lane  6) and Lck (lane  7) on c-Cbl 
tyrosine phosphorylation.  This  consequence was observed 
in  three  independent  experiments,  and was  confirmed by 
immunoprecipitation  of p120  c-cbl (data  not shown).  While 
phosphorylation of c-Cbl by these tyrosine protein kinases 
could be reconstituted in Cos-1 cells, it is worth noting that 
we were unable to show association of c-Cbl and Zap-70 in 
this system (data not shown). 
Discussion 
The results of our experiments showed that a significant 
amount  (5-10%)  of the  protooncogene  product  p120  c-cbl 
could be detected in anti-Zap-70 immunoprecipitates from 
either  activated  BI-141  T  cells  (this  report)  or  activated 
mouse  thymocytes (our unpublished  data).  Moreover,  de- 
pletion experiments confirmed that the majority (>90%) of 
the Zap-70-associated p120 was removed by anti-Cbl anti- 
bodies,  implying that  it  largely  represented  p120  c-cbl. De- 
spite  this  firm  evidence,  we  consistently  failed  to  detect 
Zap-70  in  anti-Cbl  immunoprecipitates  (13  and  this  re- 
port).  Although  the  precise  basis  for this  phenomenon  is 
not determined,  the anti-Cbl antibodies used in our exper- 
iments may not efficiently recognize c-Cbl molecules com- 
plexed  to  Zap-70.  This  possibility  appears  unlikely  how- 
ever,  since  equivalent  results  were  obtained  with  an 
antiserum  directed  against  another  domain  of c-Cbl  (our 
unpublished  data).  Alternatively,  the  lack  of detection  of 
Zap-70 in anti-Cbl immunoprecipitates  could indicate that 
only a small fraction of Zap-70 was bound to c-Cbl in acti- 
vated T  cells.  We favor this possibility. 
Figure  5.  Reconstitution of interactions between c-Cbl, 
Zap-70, and Src family kinases in Cos-1 cells. Cos-1 cells 
were transfected with the indicated cDNAs. After 3 d, pro- 
tein expression was determined by immunoblotting of total 
cell lysates (A). Levels of phosphotyrosine were ascertained 
by immunoblotting with antiphosphotyrosine antibodies (B). 
The migrations of c-Cbl, Zap-70, FynT, and Lck are indi- 
cated on  the  left, whereas those of prestained molecular 
weight markers are shown on the right. Exposures: (A) top, 
15 h; top middle, 15 h; bottom middle, 10 h; bottom, 10 h; (/3) 
48 h. 
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induced by T  cell activation.  Therefore, it is probable that 
this  association required  modification of either  or both of 
these  products in  the  course  of T  cell  activation.  Further 
support for this view was lent by our finding that phospho- 
tyrosine (but not phosphoserine) dissociated Zap-Cbl com- 
plexes  (13  and  our unpublished  data),  which implied  that 
phosphorylated tyrosine residues were crucial for the stabil- 
ity of the  interaction.  Because  both  Zap-70  and p120  c-cbl 
are tyrosine phosphorylated in activated T  cells  (6,  18), ei- 
ther could act as a docking site for the other.  One obvious 
possibility is  that  the  SH2  motifs  of Zap-70  interact  with 
sites  of tyrosine phosphorylation on c-Cbl.  Unfortunately, 
however,  we  were  unable  to  show  binding  of tyrosine- 
phosphorylated  c-Cbl  to  recombinant  Zap-70  SH2  do- 
mains  in  vitro  (our  unpublished  data).  Conversely,  it  is 
plausible  that  phosphorylated  tyrosines  on  Zap-70  were 
central to the interaction. As c-Cbl does not bear any SH2 
domain,  this  model would require  the  participation  of an 
intermediary  molecule  linking  tyrosine  phosphorylated 
Zap-70  to c-Cbl.  This  idea would also be consistent with 
the  inability  of Zap-70  to  associate  with  c-Cbl  in  Cos-1 
cells,  even  in  the  presence  of Src-related  enzymes.  Since 
c-Cbl  possesses  binding  sites  for  SH2  and  SH3  domains 
(18),  it  may interact  with  Zap-70  through  an  "adaptor" 
molecule such as Grb-2, Crk, or Nck (30). These polypep- 
tides contain both SH2 and SH3 domains,  and are known 
to mediate associations between signal transduction molecules. 
By coexpression  in  Cos-1  cells,  evidence  was  adduced 
that Zap-70 could not phosphorylate c-Cbl in the absence 
of Lck  or  FynT.  This  result  was  reminescent  of that  of 
Chan et al.  (6),  which showed that phosphorylation of cel- 
lular proteins by Zap-70 in Cos-7 cells  was also dependent 
on  coexpression  of  a  Src-like  kinase.  Importantly,  we 
found that Zap-70 augmented the extent of c-Cbl tyrosine 
phosphorylation  induced  by Lck or FynT.  On  this  basis, 
we hypothesized that Zap-70 and Lck/FynT cooperate to 
induce optimal tyrosine phosphorylation of p120  c-cbl during 
T  cell  activation.  The  relative  contribution  of each  en- 
zyme, as well as the possibility that they phosphorylate dis- 
tinct sites  on p120 c-cbl, remain to be examined. 
What is the potential role of c-Cbl in Zap-70-mediated 
signal transduction? Previous studies have shown that c-Cbl 
is  a  potent  growth  regulator  that  has  oncogenic potential 
towards  cells  of hemopoietic  and fibroblastic lineages  (15, 
16, 31, 32). While its  exact mode of action is not defined, 
p120  c-cbl has the  ability to associate with various polypep- 
tides  containing  SH2  or  SH3  domains  (18).  Therefore, 
c-Cbl may function as a large docking protein linking Zap-70 
to biochemical events such as Ras activation and lipid me- 
tabolism.  In this  context,  the formation of Zap-Cbl com- 
plexes may represent a crucial step in T  cell activation. Al- 
ternatively,  it  is possible  that  the  binding  of c-Cbl affects 
the regulation of Zap-70. For example, by associating with 
both Zap-70 and p59  fynT, c-Cbl could enhance the ability 
of FynT to phosphorylate  (and activate)  Zap-70.  This may 
be  especially  important  for  non-TCR-associated  Zap-70 
molecules, which are actually known to preferentially asso- 
ciate with c-Cbl (13).  These two possibilities  are currently 
being tested. 
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